UPC CFI 613/2024
Oct 23, 2024·EP3397329 +1 more: AIR-FLOW IN A NEBULIZER HEAD
- Case details
- StatusCase ClosedActionRevocationCategoryMain Revocation Action
- Parties
- Division
- Milan CD
- Technology
- Medical Devices · Drug Delivery · Pharmaceutical & Medical
- Language
- English
- First decided
- Nov 27, 2025
- 2025-11-27Patent maintainedRevocation meritsRevocation Action
The Milan Central Division dismissed Pari Pharma's revocation action against Philips' nebulizer patent EP 3 397 329 (unitary effect), upholding the patent after finding the prior art combinations relied upon by the claimant do not render the invention obvious to the skilled person.
Legal issues:Inventive step (nebulizer head air-flow patent)Standing under Art. 47(6) UPCAClaim construction of schematic figures - 2025-11-27Revocation Action
The Milan Central Division (full panel: Postiglione, Klein, Callewaert) rectified an obvious slip in its final decision of 27 November 2025 in the revocation action brought by Pari Pharma GmbH against Koninklijke Philips N.V. concerning EP 3 397 329. The decision had incorrectly stated that the patent is registered with unitary effect; this sentence was deleted. The parties did not object.
Legal issues:Rectification of obvious slip in decision (R. 353 RoP)Unitary patent vs. European patent with national designations
| Document title | Date | Public |
|---|---|---|
| action.communication.general | 2026-02-27 | Not public |
| Other Documents | 2026-02-27 | Not public |
| action.issueOrder.order | 2026-02-24 | Not public |
| Order | 2026-02-24 | Public |
| action.issueOrder.order | 2026-02-06 | Not public |
| Order | 2026-02-06 | Not public |
| action.phaseChange.caseClose | 2025-11-28 | Not public |
| action.issueDecision.decision | 2025-11-27 | Not public |
| Decision | 2025-11-27 | Public |
| Other Documents | 2025-10-07 | Not public |
| action.issueOrder.order | 2025-09-26 | Not public |
| Order | 2025-09-26 | Not public |
| 57595/2024/IC/MIL-CTL/UPC2025091610AM | 2025-09-16 | Not public |
| 57595/2024/IC/MIL-CTL/UPC2025091610AM | 2025-09-16 | Not public |
| Interim Conference Recording | 2025-09-16 | Not public |
| Interim Conference Recording | 2025-09-16 | Not public |
| Agenda IC | 2025-09-11 | Public |
| Receipt | 2025-08-18 | Not public |
| 2025-08-18_Response to Procedural Order Agenda for IC | 2025-08-18 | Not public |
| Acknowledgement-of-change-of-a-representative | 2025-08-11 | Not public |
| Application-RoP293-Receipt | 2025-08-11 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2025-08-11 | Not public |
| Application-RoP293 | 2025-08-11 | Not public |
| Application to change a representative (RoP293) | 2025-08-11 | Not public |
| Fix-Interim-Conference-Date | 2025-07-10 | Not public |
| Interim-Conference-Decision | 2025-07-10 | Not public |
| Written-Procedure-Closure | 2025-07-10 | Not public |
| Hearing-Dates | 2025-07-09 | Not public |
| Summons to the Interim Conference | 2025-07-09 | Public |
| Template-Order | 2025-07-09 | Not public |
| Rejoin-Amend-Patent-Defence | 2025-05-19 | Not public |
| Rejoinder to the Reply to the Defence | 2025-05-19 | Not public |
| Acknowledgement-of-lodging | 2025-04-18 | Not public |
| Philips' Rejoinder in revocation action | 2025-04-18 | Not public |
| Reply-Amend-Patent-Defence | 2025-04-18 | Not public |
| Philips' Reply in Application to amend | 2025-04-18 | Not public |
| Outcome of the Order | 2025-04-02 | Not public |
| Request timely filing final order | 2025-04-02 | Public |
| Comments by Philips | 2025-03-31 | Not public |
| Preliminary order - defendant to reply to RoP 9 request | 2025-03-25 | Not public |
| Receipt | 2025-03-24 | Not public |
| 2025-03-24_Procedural Request | 2025-03-24 | Not public |
| Acknowledgement-of-lodging | 2025-03-24 | Not public |
| HE 20 Kommissionierauftrag | 2025-03-24 | Not public |
| HE 17t Trans. HE 17 | 2025-03-24 | Not public |
| HE 22 Speditionsauftrag | 2025-03-24 | Not public |
| HE 26 Aenderungsmitteilung | 2025-03-24 | Not public |
| HE 25 Written Witness Statement Thomas Gallem | 2025-03-24 | Not public |
| HE 6t Trans. HE 6 | 2025-03-24 | Not public |
| HE 24 Written Witness Statement Peter Kallus | 2025-03-24 | Not public |
| HE 21 Delivery Note | 2025-03-24 | Not public |
| HE 27 Photographs of HE 7 | 2025-03-24 | Not public |
| HE 6a GA (Kurz) eMotion | 2025-03-24 | Not public |
| HE 24t Translation Written Witness Statement of Peter Kallus | 2025-03-24 | Not public |
| HE 19 Nachweis_Zahlungseingang_Matsuyoshi_2008 | 2025-03-24 | Not public |
| HE 7t Trans. HE 7 | 2025-03-24 | Not public |
| HE 7a eMotion GA 078D1002 | 2025-03-24 | Not public |
| HE 28 Erstmusterpruefberichte | 2025-03-24 | Not public |
| HE 6at - English Translation of Anlage HE 6a | 2025-03-24 | Not public |
| HE 9a 078U3004_002132-correct | 2025-03-24 | Not public |
| HE 23 Agreement with Matsuyoshi Co Ltd | 2025-03-24 | Not public |
| 2025-03-21_Reply to the Defence | 2025-03-24 | Not public |
| Acknowledgement-of-lodging | 2025-03-21 | Not public |
| HE 6at - English Translation of Anlage HE 6a | 2025-03-21 | Not public |
| HE 20 Kommissionierauftrag | 2025-03-21 | Not public |
| HE 6t Trans. HE 6 | 2025-03-21 | Not public |
| HE 24 Written Witness Statement Peter Kallus | 2025-03-21 | Not public |
| HE 6a GA (Kurz) eMotion | 2025-03-21 | Not public |
| HE 7t Trans. HE 7 | 2025-03-21 | Not public |
| HE 25 Written Witness Statement Thomas Gallem | 2025-03-21 | Not public |
| HE 23 Agreement with Matsuyoshi Co Ltd | 2025-03-21 | Not public |
| HE 27 Photographs of HE 7 | 2025-03-21 | Not public |
| HE 24t Translation Written Witness Statement of Peter Kallus | 2025-03-21 | Not public |
| 2025-03-21_Reply to the Defence | 2025-03-21 | Not public |
| HE 26 Aenderungsmitteilung | 2025-03-21 | Not public |
| HE 28 Erstmusterpruefberichte | 2025-03-21 | Not public |
| HE 22 Speditionsauftrag | 2025-03-21 | Not public |
| HE 17t Trans. HE 17 | 2025-03-21 | Not public |
| HE 7a eMotion GA 078D1002 | 2025-03-21 | Not public |
| HE 9a 078U3004_002132-correct | 2025-03-21 | Not public |
| HE 19 Nachweis_Zahlungseingang_Matsuyoshi_2008 | 2025-03-21 | Not public |
| HE 21 Delivery Note | 2025-03-21 | Not public |
| Hearing-Dates | 2025-02-19 | Not public |
| Summons to the oral hearing | 2025-02-19 | Public |
| Summons to the oral hearing | 2025-02-19 | Not public |
| Hearing-Dates | 2025-02-19 | Not public |
| Receipt | 2025-01-22 | Not public |
| Acknowledgement-of-lodging | 2025-01-22 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2025-01-22 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2025-01-22 | Not public |
| 2024PJT01711 confidentiality request | 2025-01-21 | Not public |
| Acknowledgement-of-lodging | 2025-01-21 | Not public |
| Exhibit 1 - Handelsregister PARI GmbH Spezialisten fuer effektive Inhalation | 2025-01-21 | Not public |
| 2024PJT01711 Statement of Defence unredacted version | 2025-01-21 | Not public |
| Exhibit 3b - 2024PJT01711 2nd aux req.amended claims marked up | 2025-01-21 | Not public |
| Exhibit 3a - 2024PJT01711 2nd aux req.amended claims.clean | 2025-01-21 | Not public |
| 2024PJT01711 Statement of Defence unredacted version | 2025-01-21 | Not public |
| Exhibit 2 - Handelsregister PARI Pharma GmbH | 2025-01-21 | Not public |
| Exhibit 3b - 2024PJT01711 2nd aux req.amended claims marked up | 2025-01-21 | Not public |
| 2024PJT01711 Statement of Defence redacted version | 2025-01-21 | Not public |
| Exhibit 3a - 2024PJT01711 2nd aux req.amended claims.clean | 2025-01-21 | Not public |
| Panel-Appointment | 2024-12-16 | Not public |
| Notification Of Service | 2024-11-26 | Not public |
| Service status | 2024-11-26 | Not public |
| Acknowledgement of access to case | 2024-11-26 | Not public |
| communicationCheck | 2024-10-30 | Not public |
| Document from EPO | 2024-10-29 | Not public |
| Letter-for-Service | 2024-10-25 | Not public |
| Panel-Appointment | 2024-10-25 | Not public |
| EPO-Request-for-case-pending | 2024-10-25 | Not public |
| Acknowledgement-of-lodging | 2024-10-25 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2024-10-25 | Not public |
| D2 WO002011089485A1 | 2024-10-23 | Not public |
| HE 6 Gebrauchsanweisung eMotion 078D1007 | 2024-10-23 | Not public |
| D7 US2005011514A1 | 2024-10-23 | Not public |
| HE 0_Copy of bank transfer | 2024-10-23 | Not public |
| D11 EP 2910268 A1 | 2024-10-23 | Not public |
| HE 18 Feature Analysis | 2024-10-23 | Not public |
| D3 EP1927373A1 | 2024-10-23 | Not public |
| HE 12 078E3400--Einatemventil-Grundkoerper-Vers-C | 2024-10-23 | Not public |
| HE 9 078B3400_000371_PDF_1 | 2024-10-23 | Not public |
| D5 US2011146670A1 | 2024-10-23 | Not public |
| D9 US2012085344A1_part1- | 2024-10-23 | Not public |
| D1 WO2016102308A1 | 2024-10-23 | Not public |
| D9 US2012085344A1_part2 | 2024-10-23 | Not public |
| HE 15 078U3001_000459_PDF_12 | 2024-10-23 | Not public |
| HE 16 078U4012_000624_PDF_9 | 2024-10-23 | Not public |
| HE 10 078E3656_005774_PDF_0-Verneblerkammer-Vers-A | 2024-10-23 | Not public |
| D10 WO2010066714A1 | 2024-10-23 | Not public |
| Patent in Suit EP_3397329_B1 | 2024-10-23 | Not public |
| HE 11 012E1720_000379_Mundstueck-Vers-E | 2024-10-23 | Not public |
| HE 13 078E3000_000298_Medikamentenkammer-Vers-C | 2024-10-23 | Not public |
| HE 8 078B3001_000381_eMotion--Vernebler--Vers-D | 2024-10-23 | Not public |
| HE 14 078B3800_000228_PDF_0 | 2024-10-23 | Not public |
| HE 1 8.5.08 SalRequest-Matsuyoshi Co Ltd. 10080812 | 2024-10-23 | Not public |
| Revocation Action | 2024-10-23 | Not public |
| HE 4 SalDelNote_ Matsuyoshi Co. Ltd. 13048126 | 2024-10-23 | Not public |
| D8 WO2014082818A1 | 2024-10-23 | Not public |
| HE 5 Fertigungsauftrag | 2024-10-23 | Not public |
| HE 2 28.5.08 SalRequest-Matsuyoshi Co Ltd. 10080812 | 2024-10-23 | Not public |
| HE 3 SalInvoice_ Matsuyoshi Co. Ltd. 20041559 | 2024-10-23 | Not public |
| D6 US2003072717A1 | 2024-10-23 | Not public |
| D4 WO2004052436A1 | 2024-10-23 | Not public |
| HE 7 GA eMotion 078D1002 | 2024-10-23 | Not public |
| HE 15.1 078U3006_003674_PDF_2 | 2024-10-23 | Not public |
| HE 17 2008-PARI-emotion-catalog-Japan | 2024-10-23 | Not public |
Pari Pharma GmbH brought a revocation action at the Milan Central Division against Koninklijke Philips N.V.'s EP 3 397 329 (air-flow in a nebuliser head). The court found claim 1 as granted lacked novelty over D1 but upheld the patent in amended form pursuant to auxiliary request 2, rejecting all obviousness attacks including the D3+D7+D5 combination because D3 teaches away from omitting the inhalation valve. A subsequent rectification order corrected an error stating the patent had unitary effect.
Any entity operating in the technical field and potentially needing freedom to operate has standing to bring a revocation action
ClaimantLegal basis: Art. 47(6) UPCANote: Court confirmed Pari Pharma had standing as a company potentially needing freedom to operate in the nebuliser field.
Claim 1 as granted lacks novelty over D1
ClaimantNote: The court accepted that claim 1 as granted is anticipated by D1; this drove the need for the patent to be maintained in amended form.
Auxiliary request 2 claim 1 is inventive over all prior art combinations relied upon by claimant
RespondentNote: Court found that D3 teaches away from omitting the inhalation valve and the skilled person would not combine D3 with D7 and D5 to arrive at the claimed invention.
Skilled person will not directly and unambiguously deduce dimensions from schematic figures
RespondentNote: Court held as a headnote principle that schematic figures cannot serve as a source of dimensional disclosure.
Combination of D3 with D7 and D5 renders auxiliary request 2 obvious
ClaimantReason: D3 is directed to a device that accumulates aerosol during exhalation using an inhalation valve — an essential feature; there is no hint to remove the valve and D3 teaches away from omitting it, so the combination is not obvious.
Attack based on Pari eMotion plus D2 or D7 plus D5 against claim 1 as amended
ClaimantLegal basis: UPC RoP front-loaded proceedings principleReason: This attack was raised for the first time at oral hearing and is precluded by the front-loaded nature of UPC proceedings; claimant should have anticipated the narrower claim construction and presented this attack earlier.
Browse other cases on this principle.
- D1Novelty-destroying
- D2Obviousness combination
- D3Obviousness combination
- D5Obviousness combination
- D7Obviousness combination
- Pari eMotion (prior art device)Obviousness combination
The court construed claim 1 as amended (auxiliary request 2) of EP 3 397 329 (nebuliser head airflow) more narrowly than the claimant anticipated, particularly regarding the 'backside opening' feature. The claimant expected the respondent would accept any opening behind the aperture surface as qualifying; the court found there was reason to anticipate the narrower construction, making the late-raised Pari eMotion attack precluded.